Autolus Therapeutics
AUTL
Autolus Therapeutics (AUTL) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| HC Wainwright & Co. | Maintained | Buy | $10.00 | Aug 3, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $10.00 from $9.00 | May 14, 2026 |
| Needham | Maintained | Buy | $10.00 | Apr 9, 2026 |
| Mizuho | Maintained | Outperform | $10.00 from $12.00 | Mar 31, 2026 |
| Needham | Maintained | Buy | $10.00 | Mar 27, 2026 |
| HC Wainwright & Co. | Initiated Coverage | Buy | $9.00 | Feb 17, 2026 |
| Needham | Maintained | Buy | $10.00 from $11.00 | Jan 12, 2026 |
| Needham | Maintained | Buy | $11.00 from $10.00 | Dec 29, 2025 |
| Needham | Maintained | Buy | $10.00 | Dec 12, 2025 |
| Needham | Maintained | Buy | $10.00 | Nov 3, 2025 |
| Needham | Maintained | Buy | $10.00 | Oct 20, 2025 |
| Wells Fargo | Maintained | Overweight | $5.00 from $6.00 | Aug 13, 2025 |
| Needham | Maintained | Buy | $10.00 | Jul 21, 2025 |
| Needham | Maintained | Buy | $10.00 | Jun 12, 2025 |
| Needham | Maintained | Buy | $10.00 | Apr 10, 2025 |
| Truist Securities | Maintained | Buy | $10.00 from $11.00 | Apr 1, 2025 |
| Wells Fargo | Maintained | Overweight | $6.00 from $8.00 | Mar 21, 2025 |
| Needham | Maintained | Buy | $10.00 | Jan 13, 2025 |
| Needham | Maintained | Buy | $10.00 | Dec 9, 2024 |
| Needham | Maintained | Buy | $10.00 | Dec 5, 2024 |
Frequently asked questions
What is the latest analyst rating on AUTL?
On Aug 3, 2026, HC Wainwright & Co. maintained Autolus Therapeutics at Buy with a price target of $10.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.